Guardant Health and Hikma Partner to Offer Cancer Screening and Comprehensive Genomic Profiling Tests in the Middle East and North AfricaPRNewsWire • 01/08/24
Guardant Health Announces $90.7 Million Registered Direct Offering with Baillie GiffordBusiness Wire • 12/21/23
Guardant Health to Participate in the 42nd Annual J.P. Morgan Healthcare ConferenceBusiness Wire • 12/20/23
Guardant Health shares slide as colon cancer test is set for FDA advisory committee reviewMarket Watch • 12/20/23
Guardant Health Announces Tentative Date of FDA Advisory Panel Review of Shield™ Blood TestBusiness Wire • 12/19/23
Cancer Research UK and Guardant Health Launch Collaboration to Advance Cancer Research and Clinical Development ActivitiesBusiness Wire • 12/04/23
Guardant Health to present data at San Antonio Breast Cancer Symposium demonstrating utility of liquid biopsy in biomarker identification, therapy selection and residual disease detectionBusiness Wire • 11/30/23
Guardant Health launches Shield blood-based screening test for colorectal cancer in South KoreaPRNewsWire • 11/13/23
Guardant Health (GH) Reports Q3 Earnings: What Key Metrics Have to SayZacks Investment Research • 11/07/23
Guardant Health Reports Third Quarter 2023 Financial Results and Increases Revenue GuidanceBusiness Wire • 11/06/23
Guardant Health, Flatiron Health Announce Integration of Guardant Genomic Profiling Tests Into OncoEMR® PlatformBusiness Wire • 10/31/23
First results from PEGASUS trial reported at ESMO show promise for use of liquid biopsy to guide adjuvant treatment of colon cancerBusiness Wire • 10/23/23
Guardant Health to Report Third Quarter 2023 Financial Results on November 6, 2023Business Wire • 10/16/23
Which Is the Better Cancer-Testing Healthcare Stock: Exact Sciences or Guardant Health?The Motley Fool • 10/08/23
Guardant Health (GH) Surges 8.8%: Is This an Indication of Further Gains?Zacks Investment Research • 09/29/23
Guardant Health Receives Coverage for Guardant Reveal™ from Geisinger Health PlanBusiness Wire • 09/06/23